Polymers for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is one of the most common diseases of the central nervous system in the middle-aged and elderly population. It is a neurodegenerative disorder, and its main clinical symptoms include the loss of established memories, a decline in learning capacity, and the buildup of β-amylo...
Saved in:
Main Authors: | Yunfeng Zhu, Haibin Xu, Chaoyan Yu, Wenting Jiang, Xiaowen Hou, Mingyue Ma, Ji Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1512941/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery system
by: Paul Pijush Kumar, et al.
Published: (2017-06-01) -
Tumor microenvironment-responsive hyperbranched polymers for controlled drug delivery
by: Yuqiong Guo, et al.
Published: (2024-12-01) -
Editorial: Biodegradable polymers for biomedical applications - volume III
by: Liqun Yang, et al.
Published: (2025-01-01) -
Polymer nanocomposites in diabetes management: advances in biosensors and drug delivery systems
by: Aniruddha Sen
Published: (2025-02-01) -
Design of 3‐aminophenol‐grafted polymer‐modified zinc sulphide nanoparticles as drug delivery system
by: Milad Abniki, et al.
Published: (2021-10-01)